ESA-PSS-M

Predicting response to erythropoiesis-stimulating agents in lower-risk MDS

1

How do you want to enter the case?

Values at the time of the ESA decision.

g/dL
g/dL
420
×10⁹/L
×10⁹/L
0600
%
%
020
IU/L
IU/L
01000
Transfusion dependence at baseline
At least one red-cell transfusion in the 8 weeks before inclusion.
Sex at birth
Used for the STAG2 signal in males.

Decision-support tool. It does not replace clinical judgement, and it is not a validated medical device. The score was derived and validated in retrospective cohorts of lower-risk MDS.